Angiotensin 1–7 treatment was able to maintain muscle strength and prevented decreases in muscle diameter and mass by activating IGF-1 and Akt pathways that also might improve insulin resistance in skeletal muscle [195]. The gene discussed is AKT1; the disease is Insulin resistance.